COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Behnood BikdeliNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: [email protected]Mahesh V. MadhavanNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: [email protected]David JiménezRespiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, SpainTaylor ChuichNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkIsaac DreyfusNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkElissa DrigginNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkCaroline Der‐NigoghossianNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkWalter AgenoDepartment of Medicine and Surgery, University of Insubria, Varese, ItalyMohammad MadjidMcGovern Medical School, University of Texas Health Science Center at Houston, Houston, TexasYutao GuoDepartment of Cardiology, Chinese PLA General Hospital, Beijing, ChinaLiang TangInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaYu HuInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaJay GiriCardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PennsylvaniaMary CushmanUniversity of Vermont Medical Center, Burlington, VermontI. QuéréDepartment of Vascular Medicine, University of Montpellier, Centre Hospitalier Universitaire Montpellier, InnoVTE F-CRIN Network, Montpellier, FranceEvangelos DimakakosOncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, GreeceC. Michael GibsonHarvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, MassachusettsGiuseppe LippiLaboratory of Clinical Chemistry and Hematology, University Hospital of Verona, Verona, ItalyEmmanuel J. FavaloroHaematology Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, AustraliaJawed FareedLoyola University Medical Center, Chicago, IllinoisJoseph A. CapriniPritzker School of Medicine, University of Chicago, Chicago, IllinoisAlfonso TafurPritzker School of Medicine, University of Chicago, Chicago, Illinois; Division of Vascular Medicine, Department of Medicine, NorthShore University HealthSystem, Skokie, IllinoisJohn BurtonNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkDominic P. FranceseClinical Trials Center, Cardiovascular Research Foundation, New York, New YorkElizabeth WangNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New YorkAnna FalangaDepartment of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, University of Milan Bicocca, Bergamo, ItalyClaire McLintockAuckland City Hospital, Auckland, New ZealandBeverley J. HuntSt Thomas' Hospital, London, United KingdomAlex C. SpyropoulosDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, New YorkGeoffrey D. BarnesCenter for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, Michigan; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MichiganJohn W. EikelboomPopulation Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, CanadaIdo WeinbergHarvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, MassachusettsSam SchulmanDepartment of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, CanadaMarc CarrierOttawa Hospital Research Institute, Ottawa, Ontario, CanadaGregory PiazzaHarvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, MassachusettsJoshua A. BeckmanVerona, Verona, Italy;Philippe Gabríel StegINSERM U1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, FACT (French Alliance for Cardiovascular Trials), Paris, France; Université Paris, Paris, France; Royal Brompton Hospital, Imperial College London, London, United KingdomGregg W. StoneClinical Trials Center, Cardiovascular Research Foundation, New York, New York; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New YorkStephan RosenkranzCologne Cardiovascular Research Center, Heart Center, Department of Cardiology, University of Cologne, Cologne, GermanySamuel Z. GoldhaberHarvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, MassachusettsSahil A. ParikhNewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New YorkManuel MonréalDepartment of Internal Medicine, Hospital Universitari Germans Trials i Pujol, Universidad Católica San Antonio de Murcia, Barcelona, SpainHarlan M. KrumholzCenter for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut; Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, ConnecticutStavros KonstantinidesCenter for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz, Mainz, GermanyJeffrey I. WeitzMcMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, CanadaGregory Y.H. LipLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, United Kingdom; Aalborg University, Aalborg, Denmark
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0